a2 Milk Company Ltd (Australia) shares hit record high: Is it time to invest?

a2 Milk Company Ltd (Australia) (ASX:A2M) shares just hit a new all-time high of $2.48. Is there still time to invest in this growth machine?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The shares of fast-growing dairy company a2 Milk Company Ltd (Australia) (ASX: A2M) have continued to climb higher today and hit a new all-time high of $2.48.

Today's gain means that its shares have climbed a staggering 40% since the start of November and a whopping 131% in the last 12 months.

November's gains were largely the result of a very positive trading update at its annual general meeting. That update revealed that during the first four months of FY 2017 sales have grown 96% over the prior corresponding period to NZ$155.2 million.

Furthermore, management revealed that demand in China continues to grow strongly. There had been concerns that changes to import regulations might hinder the company's progress in the country, but these concerns have been put to bed now in my opinion.

According to the update, Chinese Singles day volume sales of a2 Platinum formula doubled from last year. This led to a2 Platinum Stage 3 being in the top 10 Singles day products across all categories on Chinese e-commerce giant JD.com.

As a result, I believe it comes as little surprise to see its shares rally in the last month.

But are they still a buy today?

Whilst the surge in its share price in the last month may mean a2 Milk is no longer the bargain buy it was previously, I still believe that the company represents an excellent long-term buy-and-hold investment.

Its enormous growth potential more than justifies paying 30x estimated FY 2017's earnings in my opinion.

But if that is too rich for you then Bellamy's Australia Ltd (ASX: BAL) could be just the ticket. At 18x estimated FY 2017's earnings it still looks to be in bargain territory to me.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of A2 Milk and Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »